Year |
Citation |
Score |
2020 |
Le D, Liu A, Campbell MK, Yang C, Minami SS, Braithwaite SP, Czirr E. Aged Plasma and Plasma‐Derived Factors Drive Detrimental Effects in the CNS of Young Mice The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.09388 |
0.311 |
|
2019 |
Gallager I, Kheifets V, Minami SS, Czirr E, lohr s, huber n, Campbell m, Braithwaite SP. BENEFICIAL EFFECTS OF A PLASMA FRACTION ON NEUROGENESIS FOR AGE-RELATED COGNITIVE DISORDERS Innovation in Aging. 3: S90-S91. DOI: 10.1093/Geroni/Igz038.345 |
0.359 |
|
2017 |
Czirr E, Castello NA, Mosher KI, Castellano JM, Hinkson IV, Lucin KM, Baeza-Raja B, Ryu JK, Li L, Farina SN, Belichenko NP, Longo FM, Akassoglou K, Britschgi M, Cirrito JR, et al. Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity. The Journal of Experimental Medicine. PMID 28298456 DOI: 10.1084/Jem.20162011 |
0.754 |
|
2016 |
Middeldorp J, Lehallier B, Villeda SA, Miedema SS, Evans E, Czirr E, Zhang H, Luo J, Stan T, Mosher KI, Masliah E, Wyss-Coray T. Preclinical Assessment of Young Blood Plasma for Alzheimer Disease. Jama Neurology. PMID 27598869 DOI: 10.1001/Jamaneurol.2016.3185 |
0.71 |
|
2014 |
Li WW, Guo TZ, Shi X, Czirr E, Stan T, Sahbaie P, Wyss-Coray T, Kingery WS, Clark JD. Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain. 155: 2377-89. PMID 25218828 DOI: 10.1016/J.Pain.2014.09.007 |
0.488 |
|
2014 |
Kleinberger G, Yamanishi Y, Suárez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, Tahirovic S, Lleó A, Alcolea D, Fortea J, Willem M, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Science Translational Medicine. 6: 243ra86. PMID 24990881 DOI: 10.1126/Scitranslmed.3009093 |
0.584 |
|
2014 |
Kerchner GA, Czirr E, Bernstein JD, Wyss-Coray T, Rutt BK. P1-265: CEREBROSPINAL FLUID TAU, BUT NOT AMYLOID, TRACKS ATROPHY IN ALZHEIMER'S-VULNERABLE HIPPOCAMPAL SUBFIELDS Alzheimer's & Dementia. 10: P406-P406. DOI: 10.1016/j.jalz.2014.05.505 |
0.537 |
|
2014 |
Kerchner GA, Czirr E, Bernstein JD, Wyss-Coray T, Rutt BK. IC-P-166: CEREBROSPINAL FLUID TAU, BUT NOT AMYLOID, TRACKS ATROPHY IN ALZHEIMER-VULNERABLE HIPPOCAMPAL SUBFIELDS Alzheimer's & Dementia. 10: P93-P93. DOI: 10.1016/J.Jalz.2014.05.173 |
0.564 |
|
2013 |
Lucin KM, O'Brien CE, Bieri G, Czirr E, Mosher KI, Abbey RJ, Mastroeni DF, Rogers J, Spencer B, Masliah E, Wyss-Coray T. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron. 79: 873-86. PMID 24012002 DOI: 10.1016/J.Neuron.2013.06.046 |
0.587 |
|
2012 |
Czirr E, Wyss-Coray T. The immunology of neurodegeneration. The Journal of Clinical Investigation. 122: 1156-63. PMID 22466657 DOI: 10.1172/Jci58656 |
0.481 |
|
2012 |
Czirr E, Jaeger P, Wyss-Coray T. S1-02-04: Plasma proteomics as a discovery tool for novel pathways in neurodegenerative diseases Alzheimer's & Dementia. 8: P79-P80. DOI: 10.1016/J.Jalz.2012.05.189 |
0.714 |
|
2011 |
Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 477: 90-4. PMID 21886162 DOI: 10.1038/Nature10357 |
0.707 |
|
2011 |
Hahn S, Brüning T, Ness J, Czirr E, Baches S, Gijsen H, Korth C, Pietrzik CU, Bulic B, Weggen S. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure. Journal of Neurochemistry. 116: 385-95. PMID 21091478 DOI: 10.1111/J.1471-4159.2010.07118.X |
0.656 |
|
2009 |
Jäger S, Leuchtenberger S, Martin A, Czirr E, Wesselowski J, Dieckmann M, Waldron E, Korth C, Koo EH, Heneka M, Weggen S, Pietrzik CU. alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation. Journal of Neurochemistry. 111: 1369-82. PMID 19804379 DOI: 10.1111/J.1471-4159.2009.06420.X |
0.707 |
|
2009 |
Leuchtenberger S, Maler J, Czirr E, Ness J, Lichtenthaler SF, Esselmann H, Pietrzik CU, Wiltfang J, Weggen S. Nonsteroidal anti-inflammatory drugs and ectodomain shedding of the amyloid precursor protein. Neuro-Degenerative Diseases. 6: 1-8. PMID 18349521 DOI: 10.1159/000121391 |
0.638 |
|
2009 |
Lehmann S, Bruening T, Ness J, Czirr E, Bulic B, Pietrzik CU, Weggen S. P3-271: Presenilin-1 (PS1) and amyloid precursor protein (APP) mutations present in mouse models of Alzheimer's disease in their response to γ-secretase inhibitors and modulators Alzheimer's & Dementia. 5: P422-P423. DOI: 10.1016/J.Jalz.2009.04.942 |
0.678 |
|
2008 |
Czirr E, Cottrell BA, Leuchtenberger S, Kukar T, Ladd TB, Esselmann H, Paul S, Schubenel R, Torpey JW, Pietrzik CU, Golde TE, Wiltfang J, Baumann K, Koo EH, Weggen S. Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase. The Journal of Biological Chemistry. 283: 17049-54. PMID 18426795 DOI: 10.1074/Jbc.M802912200 |
0.711 |
|
2008 |
Czirr E, Cottrell BA, Serneels L, Leuchtenberger S, Schubenel R, Torpey JW, Esselmann H, Pietrzik CU, Wiltfang J, DeStrooper B, Baumann K, Koo EH, Weggen S. P4-192: Mechanism of γ-secretase cleavage: Evidence for independent generation of Aβ42 and Aβ38 peptide species Alzheimer's & Dementia. 4: T727-T728. DOI: 10.1016/J.Jalz.2008.05.2259 |
0.689 |
|
2007 |
Czirr E, Leuchtenberger S, Dorner-Ciossek C, Schneider A, Jucker M, Koo EH, Pietrzik CU, Baumann K, Weggen S. Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations. The Journal of Biological Chemistry. 282: 24504-13. PMID 17573346 DOI: 10.1074/Jbc.M700618200 |
0.717 |
|
2007 |
Weggen S, Czirr E, Leuchtenberger S, Eriksen J. Nonsteroidal anti-inflammatory drugs (NSAIDs) and derived Aβ42-lowering molecules for treatment and prevention of Alzheimer's disease (AD) Pharmacological Mechanisms in Alzheimer's Therapeutics. 167-193. DOI: 10.1007/978-0-387-71522-3_11 |
0.613 |
|
2006 |
Czirr E, Weggen S. Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds. Neuro-Degenerative Diseases. 3: 298-304. PMID 17047371 DOI: 10.1159/000095270 |
0.65 |
|
2006 |
Leuchtenberger S, Kummer MP, Kukar T, Czirr E, Teusch N, Sagi SA, Berdeaux R, Pietrzik CU, Ladd TB, Golde TE, Koo EH, Weggen S. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42. Journal of Neurochemistry. 96: 355-65. PMID 16300630 DOI: 10.1111/J.1471-4159.2005.03553.X |
0.708 |
|
2006 |
Czirr E, Leuchtenberger S, Schneider A, Koo EH, Pietrzik CU, Weggen S. O1-02-06: Genetic dissection of the PS1-ΔExon9 mutation and its attenuated response to Aβ42-lowering NSAIDs Alzheimer's & Dementia. 2: S11-S12. DOI: 10.1016/J.Jalz.2006.05.258 |
0.484 |
|
2004 |
Donkor FF, Mönnich M, Czirr E, Hollemann T, Hoyer-Fender S. Outer dense fibre protein 2 (ODF2) is a self-interacting centrosomal protein with affinity for microtubules. Journal of Cell Science. 117: 4643-51. PMID 15340007 DOI: 10.1242/Jcs.01303 |
0.588 |
|
2004 |
Hoyer-Fender S, Czirr E, Radde R, Turner JM, Mahadevaiah SK, Pehrson JR, Burgoyne PS. Localisation of histone macroH2A1.2 to the XY-body is not a response to the presence of asynapsed chromosome axes. Journal of Cell Science. 117: 189-98. PMID 14676273 DOI: 10.1242/Jcs.00851 |
0.585 |
|
Show low-probability matches. |